Pharmaceutial & Healthcare

Timetric’s 'Personal Accident and Health Insurance in Thailand, Key Trends and Opportunities to 2020' report provides a detailed outlook by product category for the Thailand personal accident and health insurance segment, and a comparison of the Thailand insurance industry with its regional counterparts. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/personal-accident-and-health-insurance-in-thailand/request-sample It provides key performance indicators such as written premium, incurred loss, loss ratio, commissions and expenses, combined ratio, total assets, total investment income and net earned premium during the review period (2011–2015) and forecast period (2015–2020). The report also analyzes distribution channels operating in the segment, gives a comprehensive overview of the Thailand economy and demographics, and provides detailed information on the competitive landscape in the country. Summary Timetric’s 'Personal Accid

Antibody Drug Conjugates are the fastest growing class of oncology therapeutics. These are monoclonal antibody based therapies which have achieved great success in the field of cancer treatment, primarily when used with cytotoxic drugs. ADC is a class of therapeutics which harnesses the antigen-selectivity of monoclonal antibodies to deliver the highly potent cytotoxic drugs to antigen expressing tumor cells. The use of monoclonal antibody directed delivery confers a therapeutic index to highly potent cytotoxic drugs, increasing both the efficacy and safety of therapy. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-antibody-drug-conjugates-drug-sales/request-sample Furthermore, in this report, we have structured the information regarding ADCs at various stages of clinical development that are under research or in collaboration, and those individually being developed by companies. The pipeline chapter provides in depth analysis of ADCs of c

Given the wealth of potential targets to overcome tumor-induced immune suppression, many novel active immunotherapies are in clinical development across a range of solid tumor types. The most advanced in development are checkpoint inhibitors. These checkpoint inhibitors have dramatically altered the natural history of hard-to-treat cancers by producing substantial clinical benefits for certain tumor types and patients. Some of these checkpoints are called PD-1, PD-L1, and CTLA-4 receptors. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-immune-checkpoint-inhibitors-market-outlook-2022/request-sample According to the report “Global Immune Checkpoint Inhibitors Market Outlook 2022”, the global immune checkpoint inhibitors market is anticipated to cross US$ 25 Billion by 2022. The report provides a detailed analysis of the global immune checkpoint inhibitors market. The report also provides the current and forecasted market for immune checkpo

Gene therapy is one of the most widely researched fields in the healthcare industry. The high potential of gene therapy to cure various chronic diseases makes it a popular research area. Various researches are being performed across the globe to explore the potential of gene therapy for the treatment of incurable diseases, such as diabetes, cancer, and HIV amongst others. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-and-us-gene-therapy-market-forecast-to-2020/request-sample According to RNCOS’ new research report "Global & US Gene Therapy Market Forecast to 2020”, most of the gene therapy researches are being focused on finding the treatment for cancer, followed by genetic diseases and neurological disorders, respectively. In this context, the gene therapy application chapter of the report provides a comprehensive overview of various diseases in which the gene therapy is used, along with the current and future market size of gen

This report studies Vitiligo Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-vitiligo-drug-market-professional-survey-report-2018/request-sample This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Aclaris Therapeutics Inc Arrien Pharmaceuticals LLC Bristol-Myers Squibb Co Celgene Corp Clinuvel Pharmaceuticals Ltd Incyte Corp On the basis of produ ARN-4079 ATI-50001 AX-1602 Ruxolitinib Phosphate VLRX-001 Others By Application, the market can be split into Clinic Hospital Others Browse Full Research Report With TOC:   https://www.radiantinsights.com/research/global-vitiligo-drug-market-professional-surve